ResMed Inc (RMD)vsUtah Medical Products Inc (UTMD)
RMD
ResMed Inc
$226.31
-0.82%
HEALTHCARE · Cap: $33.31B
UTMD
Utah Medical Products Inc
$63.71
-0.14%
HEALTHCARE · Cap: $204.39M
Smart Verdict
WallStSmart Research — data-driven comparison
ResMed Inc generates 13914% more annual revenue ($5.40B vs $38.52M). UTMD leads profitability with a 29.3% profit margin vs 27.5%. RMD appears more attractively valued with a PEG of 1.39. RMD earns a higher WallStSmart Score of 70/100 (B).
RMD
Strong Buy70
out of 100
Grade: B
UTMD
Hold48
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+14.4%
Fair Value
$303.30
Current Price
$226.31
$76.99 discount
Margin of Safety
-173.3%
Fair Value
$23.32
Current Price
$63.71
$40.39 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 35.2%
Safe zone — low bankruptcy risk
Every $100 of equity generates 26 in profit
Keeps 28 of every $100 in revenue as profit
Strong operational efficiency at 31.1%
Keeps 29 of every $100 in revenue as profit
Reasonable price relative to book value
Areas to Watch
No major concerns identified
Smaller company, higher risk/reward
Expensive relative to growth rate
Revenue declined 1.2%
Earnings declined 6.4%
Comparative Analysis Report
WallStSmart ResearchBull Case : RMD
The strongest argument for RMD centers on Operating Margin, Altman Z-Score, Return on Equity. Profitability is solid with margins at 27.5% and operating margin at 35.2%. Revenue growth of 11.0% demonstrates continued momentum.
Bull Case : UTMD
The strongest argument for UTMD centers on Operating Margin, Profit Margin, Price/Book. Profitability is solid with margins at 29.3% and operating margin at 31.1%.
Bear Case : RMD
No major red flags identified for RMD, but monitor valuation.
Bear Case : UTMD
The primary concerns for UTMD are Market Cap, PEG Ratio, Revenue Growth.
Key Dynamics to Monitor
RMD profiles as a mature stock while UTMD is a declining play — different risk/reward profiles.
RMD carries more volatility with a beta of 0.89 — expect wider price swings.
RMD is growing revenue faster at 11.0% — sustainability is the question.
Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
RMD scores higher overall (70/100 vs 48/100), backed by strong 27.5% margins and 11.0% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
ResMed Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.
Visit Website →Utah Medical Products Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The company is headquartered in Midvale, Utah.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?